MannKind reported $27.14M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
Adma Biologics USD 109.73M 59.73M Jun/2025
Dynavax Technologies USD 73.34M 16.79M Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Halozyme Therapeutics USD 316.34M 11.72M Jun/2025
Insmed USD 55.03M 7.29M Jun/2025
MacroGenics USD 12.53M 8.22M Jun/2025
MannKind USD 27.14M 1.76M Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Novo Nordisk DKK 86.37B 6.74B Mar/2025
Pfizer USD 16.09B 1.35B Jun/2025
Sanofi 8.21B 7.76B Jun/2025
Xencor USD 47.55M 9.77M Jun/2025